Back to Search
JIM SEYMOUR, MD
MD
Psychiatry Physician
NPI: 1003010653Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
25853(AZ)
Research & Publications (20)
Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses.
PMID 19504545·Health Econ·2010
8-other
The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.
PMID 19625344·Ann Oncol·2010
8-other
Key stakeholders' experiences and views of the NHS End of Life Care Programme: findings from a national evaluation.
PMID 19433472·Palliat Med·2009
8-other
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.
PMID 19264918·Blood·2009
4-observational
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
PMID 19230772·Lancet Oncol·2009
3-trial
Fruit and vegetable intake among adolescents and adults in the United States: percentage meeting individualized recommendations.
PMID 19295947·Medscape J Med·2009
4-observational
Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study.
PMID 19197729·Leuk Lymphoma·2009
3-trial
In vivo evaluation of a neural stem cell-seeded prosthesis.
PMID 19287078·J Neural Eng·2009
7-preclinical
An in vivo comparison of the efficacy of CSL box jellyfish antivenom with antibodies raised against nematocyst-derived Chironex fleckeri venom.
PMID 19429250·Toxicol Lett·2009
4-observational
Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.
PMID 19197732·Leuk Lymphoma·2009
3-trial
Effect of a home exercise video programme in patients with chronic obstructive pulmonary disease.
PMID 19229454·J Rehabil Med·2009
2-rct
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.
PMID 19220531·Intern Med J·2009
6-review
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia.
PMID 19641525·Leukemia·2009
8-other
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group.
PMID 19570964·Ann Oncol·2009
8-other
Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma.
PMID 19197721·Leuk Lymphoma·2009
5-case
Predicting durable remissions following thalidomide therapy for relapsed myeloma.
PMID 19194832·Leuk Lymphoma·2009
3-trial
Secondary flow mixing due to biofilm growth in capillaries of varying dimensions.
PMID 19191352·Biotechnol Bioeng·2009
8-other
Barriers to achieving care at home at the end of life: transferring patients between care settings using patient transport services.
PMID 19643950·Palliat Med·2009
4-observational
Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?
PMID 19638019·Br J Haematol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4110 W SWEETWATER DR
TUCSON, AZ 85745 - Phone
- (520) 743-2150
Quick Facts
- NPI
- 1003010653
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile